110 related articles for article (PubMed ID: 7879040)
1. Soluble CTLA4Ig modifies acute rejection of rat lung allografts without blocking accumulation of key cytokine transcripts.
Matsumura Y; Zuo XJ; Prehn J; Linsley P; Marchevsky A; Kass R; Matloff J; Jordan SC
Transplant Proc; 1995 Feb; 27(1):406-8. PubMed ID: 7879040
[No Abstract] [Full Text] [Related]
2. Soluble CTLA4Ig modifies parameters of acute inflammation in rat lung allograft rejection without altering lymphocytic infiltration or transcription of key cytokines.
Matsumura Y; Zuo XJ; Prehn J; Linsley PS; Marchevsky A; Kass RM; Matloff JM; Jordan SC
Transplantation; 1995 Feb; 59(4):551-8. PubMed ID: 7533346
[TBL] [Abstract][Full Text] [Related]
3. Review of CTLA4Ig use for allograft immunosuppression.
Lin H; Wei RQ; Gordon D; Linsley P; Turka LA; Bolling SF
Transplant Proc; 1994 Dec; 26(6):3200-1. PubMed ID: 7998114
[No Abstract] [Full Text] [Related]
4. CD28-pathway blockade with CTLA4Ig leads to prolongation of small bowel transplant survival in rats.
Pescovitz MD; Yang R; Liu Q; Collins MH; Grosfeld JL
Transplant Proc; 1994 Jun; 26(3):1618-9. PubMed ID: 8030059
[No Abstract] [Full Text] [Related]
5. Importance of the CD28/B7 costimulatory pathway in the development of chronic ductopenic rejection in a new model of orthotopic rat liver allotransplantation.
Mark W; Hechenleitner P; Sayegh MH; Hancock WW; Candinas D
Transplant Proc; 1997; 29(1-2):1029. PubMed ID: 9123182
[No Abstract] [Full Text] [Related]
6. Prevention of acute lung allograft rejection in rat by CTLA4Ig.
Shiraishi T; Yasunami Y; Takehara M; Uede T; Kawahara K; Shirakusa T
Am J Transplant; 2002 Mar; 2(3):223-8. PubMed ID: 12096784
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cytokine expression in an animal model of acute liver allograft rejection.
Egawa H; Martinez OM; Quinn MB; So S; Esquivel CO; Krams SM
Transplant Proc; 1995 Feb; 27(1):505-6. PubMed ID: 7879079
[No Abstract] [Full Text] [Related]
8. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
Nickerson P; Pacheco-Silva A; O'Connell PJ; Steurer W; Kelley VR; Strom TB
Transplant Proc; 1993 Feb; 25(1 Pt 2):984-5. PubMed ID: 8442291
[No Abstract] [Full Text] [Related]
9. Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas.
Kita Y; Li XK; Ohba M; Funeshima N; Enosawa S; Nogimura H; Ohi S; Kageyama Y; Matsushita K; Ito Y; Takahashi T; Suzuki K; Suzuki S; Kazui T
Transplant Proc; 2000 Nov; 32(7):2036-7. PubMed ID: 11120055
[No Abstract] [Full Text] [Related]
10. CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients.
Kato H; Onodera K; Chandraker A; Volk HD; Sayegh MH; Kupiec-Weglinski JW
Transplant Proc; 1998 Jun; 30(4):1063-4. PubMed ID: 9636430
[No Abstract] [Full Text] [Related]
11. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplant Proc; 1999; 31(1-2):1244. PubMed ID: 10083555
[No Abstract] [Full Text] [Related]
12. Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig.
Iwasaki N; Gohda T; Yoshioka C; Murakami M; Inobe M; Minami A; Uede T
Transplantation; 2002 Feb; 73(3):334-40. PubMed ID: 11884927
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of cytokine genes by CD45RB monoclonal antibody in renal allograft rejection.
Ogasa N; Jevnikar AM; Zhang Z; Zhong R; Yin Z; Li X; Quan D; Garcia BM; Stiller CR; Grant DR
Transplant Proc; 1995 Feb; 27(1):398. PubMed ID: 7879036
[No Abstract] [Full Text] [Related]
14. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection.
Nadeau K; Azuma H; Chandraker A; Sayegh MH; Tilney NL
Transplant Proc; 1997; 29(1-2):1038. PubMed ID: 9123187
[No Abstract] [Full Text] [Related]
16. Lipid-mediated ex vivo gene transfer of viral interleukin 10 in rat lung allotransplantation.
Itano H; Mora BN; Zhang W; Ritter JH; McCarthy TJ; Yew NS; Mohanakumar T; Patterson GA
J Thorac Cardiovasc Surg; 2001 Jul; 122(1):29-38. PubMed ID: 11436034
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
Tu Y; Rehman A; Flye MW
Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
[No Abstract] [Full Text] [Related]
18. Effect of combined OX40Ig and CTLA4Ig gene local transfer on allograft rejection and the underlying mechanisms.
Zhang J; Miao Q; Yang Y; Xiao B; Liu B; Cao J; Hao XY; Wang SW; Guo SZ
J Surg Res; 2012 Dec; 178(2):949-58. PubMed ID: 22694937
[TBL] [Abstract][Full Text] [Related]
19. Graft cytokine mRNA activity in rat single lung transplants by reverse transcription-polymerase chain reaction: effect of cyclosporine.
Francalancia NA; Wang SC; Thai NL; Aeba R; Simmons RL; Yousem SA; Hardesty RL; Griffith BP
J Heart Lung Transplant; 1992; 11(6):1041-5. PubMed ID: 1457427
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
Greenstein SM; Sun S; Schechner RS; Tellis VA
Transplant Proc; 1997; 29(1-2):1065-6. PubMed ID: 9123201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
